Anakinra or Kineret for diabetes - improves blood glucose

Treatment with a drug anakinra that is Kineret has been found to improves blood glucose levels and secretion of insulin by the beta-cells of the pancreas in patients with type 2 diabetes.

Anakinra or Kineret blocks an inflammatory compound in human body called interleukin 1 and is usually used to treat arthritis.

No serious side effects have been identified in anakinra users. No patient of Anakinra developed excessively low blood glucose levels as identified by the research.